Literature DB >> 7533770

Therapeutic controversies: clinical treatment of benign prostatic hyperplasia.

J Geller1, A Kirchenbaum, H Lepor, A C Levine.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7533770     DOI： 10.1210/jcem.80.3.7533770

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  2 in total

Review 1.  Serenoa repens (Permixon). A review of its pharmacology and therapeutic efficacy in benign prostatic hyperplasia.

Authors:  G L Plosker; R N Brogden
Journal:  Drugs Aging       Date:  1996-11       Impact factor: 3.923

Review 2.  Treatment options for benign prostatic hyperplasia.

Authors:  A J Portis; D R Mador
Journal:  Can Fam Physician       Date:  1997-08       Impact factor: 3.275
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.